These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 21964202)
1. Addressing potent single molecule AFM study in prediction of swelling and dissolution rate in polymer matrix tablets. Govedarica B; Sovány T; Pintye-Hódi K; Skarabot M; Baumgartner S; Muševič I; Srčič S Eur J Pharm Biopharm; 2012 Jan; 80(1):217-25. PubMed ID: 21964202 [TBL] [Abstract][Full Text] [Related]
2. A new approach combining different MRI methods to provide detailed view on swelling dynamics of xanthan tablets influencing drug release at different pH and ionic strength. Mikac U; Sepe A; Kristl J; Baumgartner S J Control Release; 2010 Aug; 145(3):247-56. PubMed ID: 20417675 [TBL] [Abstract][Full Text] [Related]
3. Use of xanthan and its binary blends with synthetic polymers to design controlled release formulations of buccoadhesive nystatin tablets. Sakeer K; Al-Zein H; Hassan I; Martin GP; Nokhodchi A Pharm Dev Technol; 2010; 15(4):360-8. PubMed ID: 19772376 [TBL] [Abstract][Full Text] [Related]
4. Properties of sustained release hot-melt extruded tablets containing chitosan and xanthan gum. Fukuda M; Peppas NA; McGinity JW Int J Pharm; 2006 Mar; 310(1-2):90-100. PubMed ID: 16413153 [TBL] [Abstract][Full Text] [Related]
5. Xanthan gum as a rate-controlling polymer for the development of alcohol resistant matrix tablets and mini-tablets. Lazzari A; Kleinebudde P; Knop K Int J Pharm; 2018 Jan; 536(1):440-449. PubMed ID: 29225098 [TBL] [Abstract][Full Text] [Related]
6. Release of pentoxifylline from xanthan gum matrix tablets. El-Gazayerly ON Drug Dev Ind Pharm; 2003 Feb; 29(2):241-6. PubMed ID: 12648021 [TBL] [Abstract][Full Text] [Related]
7. Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets. Viridén A; Wittgren B; Larsson A Eur J Pharm Sci; 2009 Feb; 36(2-3):297-309. PubMed ID: 19038336 [TBL] [Abstract][Full Text] [Related]
8. Formulation and evaluation of natural gum-based sustained release matrix tablets of flurbiprofen using response surface methodology. Shah SN; Asghar S; Choudhry MA; Akash MS; ur Rehman N; Baksh S Drug Dev Ind Pharm; 2009 Dec; 35(12):1470-8. PubMed ID: 19929206 [TBL] [Abstract][Full Text] [Related]
9. The use of a combination of different MR methods to study swelling of hydrophilic xanthan matrix tablets at different pHs. Mikac U; Sepe A; Kristl J; Baumgartner I Prilozi; 2012; 33(1):391-5. PubMed ID: 23037184 [TBL] [Abstract][Full Text] [Related]
10. Effect of calcium ions on the gelling and drug release characteristics of xanthan matrix tablets. Baumgartner S; Pavli M; Kristl J Eur J Pharm Biopharm; 2008 Jun; 69(2):698-707. PubMed ID: 18248802 [TBL] [Abstract][Full Text] [Related]
11. The Influence of High Drug Loading in Xanthan Tablets and Media with Different Physiological pH and Ionic Strength on Swelling and Release. Mikac U; Sepe A; Baumgartner S; Kristl J Mol Pharm; 2016 Mar; 13(3):1147-57. PubMed ID: 26866780 [TBL] [Abstract][Full Text] [Related]
12. Studies in release behavior of diltiazem HCl from matrix tablets containing (hydroxypropyl)methyl cellulose and xanthan gum. Gohel MC; Amin AF; Patel KV; Panchal MK Boll Chim Farm; 2002; 141(1):21-8. PubMed ID: 12064053 [TBL] [Abstract][Full Text] [Related]
13. Influence of sodium dodecyl sulfate on swelling, erosion and release behavior of HPMC matrix tablets containing a poorly water-soluble drug. Zeng A; Yuan B; Fu Q; Wang C; Zhao G Pharm Dev Technol; 2009; 14(5):499-505. PubMed ID: 19743948 [TBL] [Abstract][Full Text] [Related]
14. Sustained-release from layered matrix system comprising chitosan and xanthan gum. Phaechamud T; Ritthidej GC Drug Dev Ind Pharm; 2007 Jun; 33(6):595-605. PubMed ID: 17613024 [TBL] [Abstract][Full Text] [Related]
15. Single molecule study of xanthan conformation using atomic force microscopy. Camesano TA; Wilkinson KJ Biomacromolecules; 2001; 2(4):1184-91. PubMed ID: 11777391 [TBL] [Abstract][Full Text] [Related]
16. Imaging of individual biopolymers and supramolecular assemblies using noncontact atomic force microscopy. McIntire TM; Brant DA Biopolymers; 1997 Aug; 42(2):133-46. PubMed ID: 9234993 [TBL] [Abstract][Full Text] [Related]
17. The release mechanism of an oral controlled-release delivery system for indomethacin. Talukdar MM; Rombaut P; Kinget R Pharm Dev Technol; 1998 Feb; 3(1):1-6. PubMed ID: 9532594 [TBL] [Abstract][Full Text] [Related]
18. A model for the drug release from a polymer matrix tablet--effects of swelling and dissolution. Borgquist P; Körner A; Piculell L; Larsson A; Axelsson A J Control Release; 2006 Jul; 113(3):216-25. PubMed ID: 16797098 [TBL] [Abstract][Full Text] [Related]
19. Design, development and in-vitro evaluation of metoprolol tartrate tablets containing xanthan-tragacanth. Rasul A; Iqbal M; Murtaza G; Waqas MK; Hanif M; Khan SA; Bhatti NS Acta Pol Pharm; 2010; 67(5):517-22. PubMed ID: 20873420 [TBL] [Abstract][Full Text] [Related]
20. Aqueous coating dispersion (pseudolatex) of zein improves formulation of sustained-release tablets containing very water-soluble drug. Li XN; Guo HX; Heinamaki J J Colloid Interface Sci; 2010 May; 345(1):46-53. PubMed ID: 20129615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]